The results demonstrated that the addition of ASOs to organoids overexpressing PTBP3 significantly reduced organoid viability (Figure 4i) and compromised the invasive growth potential of organoids derived from primary gastric cancer tissues (Figure 4j,k). This evidence concerns the gene PTBP3 and gastric cancer.